Back
Kineta 10K Form
Sell
21
KA
Kineta
Last Price:
0.45
Seasonality Move:
-50.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KA News And Ratings
See the #1 stock for the next 7 days that we like better than KA
KA Financial Statistics
Sales & Book Value
| Annual Sales: | $5.44M |
|---|---|
| Cash Flow: | $-4.01M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.56 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.50000 |
|---|---|
| Net Income (TTM): | $-17.89M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Kineta Earnings Forecast
Key Kineta Financial Ratios
- The Research & Development expenses have been 165.80% of Revenue.
- The Interest Expense is -2.39% of Operating Income.
- The Net Earning history of KA is -259.08% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 1 years.
Kineta Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KA |
| Website: | kinetabio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |